Analysis of Genus PLC (GNS)
Genus PLC (GNS) is showing some interesting price movements and technical indicators based on the provided data:
1. Price Movement:
- The closing prices for Genus PLC have been fluctuating between 0.308 and 0.372 in the recent days.
- There was a significant price increase on one day, with the price reaching 1802.000, showing high volatility.
2. Technical Indicators:
- RSI Indicator: The Relative Strength Index (RSI) values are around 48-51, indicating a neutral to slightly bullish sentiment.
- MACD Indicator: The Moving Average Convergence Divergence (MACD) values show negative values, suggesting a bearish trend.
- Moving Averages: The Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) are providing different levels of support and resistance.
3. Overall Analysis:
- The price movements and technical indicators suggest that Genus PLC is experiencing volatility and mixed signals.
- Traders and investors may need to exercise caution and conduct further analysis before making any trading decisions.
- It would be advisable to monitor the price movements closely and consider other fundamental factors before taking any positions in Genus PLC.
Please note that this analysis is based on the provided data and should be supplemented with additional research for a comprehensive understanding of Genus PLC's current situation.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released After Hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.
Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.
Financials:
- Cash flow: Operating cash flow TTM is $110,563,000,320 and levered free cash flow TTM is $84,726,874,112.
- Balance sheet: Total cash MRQ is $67,150,000,128, total debt MRQ is $104,590,000,128, current ratio MRQ is 1.037, book value per share MRQ is $4.837, total cash per share MRQ is $4.379, and total debt to equity MRQ is 140.968.
- Profit margin: 26.306%.
- Fiscal year ends: September 30, 2023.
- Income statement: EBITDA is $131,393,000,000, revenue TTM is $381,623,009,280, diluted EPS TTM is $6.43, gross profit TTM is $169,148,000,000, revenue per share TTM is $24.537, net income to common TTM is $100,389,003,264, quarterly revenue growth is -4.3%, and quarterly earnings growth YoY is -2.2%.
- Operating margin: 30.743%.
- Most recent quarter: March 31, 2024.
- Return on assets TTM: 22.073999%.
- Return on equity TTM: 147.25%.
Stock statistics:
- Short ratio: 1.53.
- Float shares: 15,308,320,742.
- Shares short: 99,287,450.
- Average 10-day volume: 46,860,048.
- Average 90-day volume: 57,498,254.
- Shares outstanding: 15,334,099,968.
- Percent held by insiders: 5.22%.
- Percent held by institutions: 57.589%.
- Short percent of shares outstanding: 0.65%.
Valuation metrics:
- PEG ratio: 26.319502.
- Forward PE: 26.319502.
- Trailing PE: 29.59409.
- Enterprise value: $2,950,762,332,160.
- Price to book MRQ: 39.3405.
- Price to sales TTM: 7.646095.
- Enterprise to EBITDA: 22.763.
- Enterprise to revenue: 7.732.
- Market capitalization: $2,917,925,650,432.
Stock price summary:
- Beta: 1.264.
- 50-day moving average: $176.2646.
- 200-day moving average: $181.0429.
- 52-week low: $164.08.
- 52-week high: $199.62.
- 52-week change: 6.853%.
Dividends and splits:
- Payout ratio: 14.93%.
- Dividend date: May 16, 2024.
- Last split date: August 31, 2020.
- Ex-dividend date: May 10, 2024.
- Last split factor: 4-for-1 split.
- Forward annual dividend rate: $1.
- 5-year average dividend yield: 0.73%.
- Forward annual dividend yield: 0.5255%.
- Trailing annual dividend rate: $0.97.
- Trailing annual dividend yield: 0.5097%.
Income statement 💸
Here are the revenue figures for the company over the past four fiscal years:
1. Fiscal Year 2023: Sales of $383,285,000,000
2. Fiscal Year 2022: Sales of $394,328,000,000
3. Fiscal Year 2021: Sales of $365,817,000,000
4. Fiscal Year 2020: Sales of $274,515,000,000
From the data, we can observe the following trends:
- The company experienced a decrease in revenue from FY 2022 to FY 2023.
- Prior to that, there was an increase in revenue from FY 2021 to FY 2022.
- The highest revenue was recorded in FY 2022.
- There was a significant increase in revenue from FY 2020 to FY 2021.
These trends indicate fluctuations in the company's revenue over the past four fiscal years, with both increases and decreases in sales figures.
Balance Sheet
These are balance sheets. Here are the conclusions:
1. The total assets have been increasing over the years, reaching the highest value in 2023 at $352,755,000,000.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2023 at $217,350,000,000.
4. Total liabilities have also been increasing, reaching the highest value in 2023 at $302,083,000,000.
5. Shareholders' equity has been fluctuating, with the highest value in 2019 at $90,488,000,000.
6. The company has been relying more on non-current assets and debt to finance its operations over the years.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:
1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has been consistently positive, indicating that the company's core business operations are generating cash.
3. The company has been paying a significant amount in income taxes each year, with the highest amount paid in 2021.
4. The company has been consistently paying interest on its debts, with varying amounts each year.
5. The company has been engaging in financing activities such as issuing and repurchasing common stock, issuing long-term debt, and making other financing charges.
6. Investing activities show a mix of acquisitions, investments, and capital expenditures over the years.
7. The company's end cash position has been fluctuating, reaching its highest value in 2020.
8. The company has been paying dividends to its shareholders, with varying amounts each year.
These conclusions provide insights into the company's financial performance and how it has been managing its cash flow over the years.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:
1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This also indicates growth from the EPS of $1.35 in the same quarter last year.
3. Looking at the estimates for the current year ending on September 30, 2024, the average estimated EPS is $6.10, ranging from a low estimate of $5.95 to a high estimate of $6.41. This reflects an increase from the EPS of $5.67 for the previous year.
4. For the next year ending on September 30, 2025, the average estimated EPS is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This suggests a growth trajectory from the EPS of $6.10 in the current year.
Overall, the analysts' estimates point towards a positive outlook for the company's earnings per share, showing a trend of improvement and growth in the upcoming quarters and years.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:
1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, showing a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, showing a significant sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.
These estimates indicate a positive growth trend in both quarterly and annual sales for the company, with a more significant increase expected in the next fiscal year.
Growth estimates
Based on the consensus estimates provided:
- The current year growth rate is 7.6%
- The next quarter growth rate is 5.1%
- The current quarter growth rate is 5.1%
- The next year growth rate is 9.7%
- The average annual growth rate for the next 5 years is 9.7%
- The average annual growth rate for the past 5 years is 20.1%
It can be observed that the growth rates are expected to be relatively stable in the near future, with a slight increase in the next year compared to the current year. However, the company has experienced a significant decrease in growth rate over the past 5 years compared to the future estimates.
Price target
The analysts' forecast for the future price of the security is as follows:
- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security, with the low end at $164, the high end at $275, and the average forecast at $204.58. The current price of the security is $192.25, which is below the average and median forecasted prices. Investors should consider these forecasts along with other factors when making investment decisions.MACD of GNS